Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when single‑drug therapy is insufficient.

GNH USA supplies Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide is indicated for hypertension and works within the cardiovascular system to lower blood pressure. - Hypertension: provides additive blood‑pressure reduction when monotherapy does not achieve target levels. - Hypertensive patients with edema: counteracts amlodipine‑induced peripheral edema while controlling pressure. - Hypertension with fluid retention: adds diuretic effect of hydrochlorothiazide to improve overall control.

Adverse reactions may appear as either frequent, mild events or rare, serious conditions.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness: especially after the first doses. - Peripheral edema: swelling of ankles or feet. - Flushing: transient warmth sensation. - Fatigue: general tiredness. - Increased urination: due to the diuretic component.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Hyperkalemia or hyponatremia: electrolyte disturbances. - Acute kidney injury: sudden decline in renal function. - Angio‑edema: swelling of lips, tongue or airway. - Liver enzyme elevation: abnormal hepatic function tests. - Blood dyscrasias: rare blood‑cell abnormalities.

Before prescribing this combination, clinicians should evaluate patient history and monitor key parameters. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Electrolyte balance: check serum potassium and sodium levels, especially with diuretic use. - Hepatic impairment: use caution in patients with liver disease. - Pregnancy: avoid use; drug is contraindicated in the second and third trimesters. - Concomitant antihypertensives: monitor for additive hypotensive effect. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide may interact with several drug classes; clinicians should review patient medication lists.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): increase amlodipine exposure. - Lithium: concurrent use can raise lithium levels and toxicity risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response. - ACE inhibitors or other ARBs: additive effect on potassium and renal function. - Antidiabetic agents: may enhance glucose‑lowering effect, requiring dose adjustment.